JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

IQVIA Holdings Inc

Open

SectorHealthcare

179.36 -10.94

Overview

Share price change

24h

Current

Min

175.61

Max

201.6

Key metrics

By Trading Economics

Income

66M

332M

Sales

83M

4.1B

P/E

Sector Avg

31.632

84.243

Profit margin

8.098

Employees

91,000

EBITDA

102M

883M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+28.82% upside

Dividends

By Dow Jones

Next Earnings

5 Feb 2026

Market Stats

By TradingEconomics

Market Cap

1.9B

39B

Previous open

190.3

Previous close

179.36

News Sentiment

By Acuity

30%

70%

67 / 352 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

IQVIA Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Feb 2026, 00:00 UTC

Hot Stocks

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 Feb 2026, 22:55 UTC

Earnings

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 Feb 2026, 21:44 UTC

Earnings

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 Feb 2026, 21:39 UTC

Earnings

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 Feb 2026, 00:00 UTC

Earnings

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 Feb 2026, 00:00 UTC

Earnings

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 Feb 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 Feb 2026, 23:45 UTC

Earnings

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 Feb 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 Feb 2026, 22:59 UTC

Acquisitions, Mergers, Takeovers

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 Feb 2026, 22:30 UTC

Earnings

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 Feb 2026, 22:30 UTC

Earnings

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 Feb 2026, 22:21 UTC

Earnings

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 Feb 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 Feb 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 Feb 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4 Feb 2026, 21:53 UTC

Earnings

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 Feb 2026, 21:51 UTC

Earnings

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 Feb 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 Feb 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

4 Feb 2026, 21:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

4 Feb 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4 Feb 2026, 21:45 UTC

Earnings

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 Feb 2026, 21:44 UTC

Earnings

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 Feb 2026, 21:43 UTC

Earnings

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 Feb 2026, 21:41 UTC

Earnings

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 Feb 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 Feb 2026, 21:30 UTC

Earnings

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 Feb 2026, 21:30 UTC

Earnings

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 Feb 2026, 21:30 UTC

Earnings

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Peer Comparison

Price change

IQVIA Holdings Inc Forecast

Price Target

By TipRanks

28.82% upside

12 Months Forecast

Average 262.5 USD  28.82%

High 290 USD

Low 230 USD

Based on 11 Wall Street analysts offering 12 month price targets forIQVIA Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

8

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

150.68 / 153.45Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

67 / 352 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat